Khuhaprema Thiravud, Sangrajrang Suleeporn, Lalitwongsa Somkiat, Chokvanitphong Vanida, Raunroadroong Tawarat, Ratanachu-Ek Tawee, Muwonge Richard, Lucas Eric, Wild Christopher, Sankaranarayanan Rengaswamy
National Cancer Institute, Bangkok, Thailand.
BMJ Open. 2014 Jan 15;4(1):e003671. doi: 10.1136/bmjopen-2013-003671.
Colorectal cancer (CRC) is the third-most and fifth-most common cancer in men and women, in Thailand. The increasing CRC incidence and mortality can be reduced by screening and treating adenomas and early cancers. A pilot CRC screening programme using immunochemical faecal occult blood testing (iFOBT) and colonoscopy for test-positives were implemented through the routine Government Health Services in Lampang Province, to inform the acceptability, feasibility and scaling-up of screening in Thailand. This report describes the implementation, coverage and performance indicators of this project.
A target population aged 50-65 years was informed about and invited face to face to undergo CRC screening by community health workers (HWs). The HWs provided faecal sample collection kits and participants brought their samples to one of the primary health units or community hospitals where nurses performed iFOBT. iFOBT-positive persons were referred for colonoscopy at the Lampang cancer hospital, and endoscopic polypectomy/biopsies were performed according to the colonoscopic findings. Those with confirmed CRC received appropriate treatment.
Of the 127 301 target population, 62.9% were screened using iFOBT between April 2011 and November 2012. Participation was higher among women (67.8%) than men (57.8%) and lower in 50-54 year-old persons than in 60-65-year-olds. Of those screened, 873 (1.1%) were found positive; positivity was higher in men (1.2%) than in women (1.0%). To date 627 (72.0%) iFOBT-positive persons have had colonoscopy in which 3.7% had CRC and 30.6% had adenomas.
The successful implementation of the pilot CRC screening with satisfactory process measures indicate the feasibility of scaling-up organised CRC screening through existing health services in Thailand.
在泰国,结直肠癌(CRC)是男性中第三常见、女性中第五常见的癌症。通过筛查和治疗腺瘤及早期癌症,可降低结直肠癌不断上升的发病率和死亡率。在南邦府,通过常规政府卫生服务实施了一项试点结直肠癌筛查计划,该计划采用免疫化学粪便潜血试验(iFOBT),并对检测呈阳性者进行结肠镜检查,以了解在泰国进行筛查的可接受性、可行性及扩大规模的情况。本报告描述了该项目的实施情况、覆盖范围及绩效指标。
向50 - 65岁的目标人群宣传并由社区卫生工作者(HWs)当面邀请其接受结直肠癌筛查。HWs提供粪便样本采集试剂盒,参与者将样本带到其中一个初级卫生单位或社区医院,由护士进行iFOBT。iFOBT呈阳性的人员被转诊至南邦癌症医院进行结肠镜检查,并根据结肠镜检查结果进行内镜息肉切除术/活检。确诊为结直肠癌的患者接受适当治疗。
在2011年4月至2012年11月期间,127301名目标人群中有62.9%使用iFOBT进行了筛查。女性的参与率(67.8%)高于男性(57.8%),50 - 54岁人群的参与率低于60 - 65岁人群。在接受筛查的人群中,873人(1.1%)检测呈阳性;男性的阳性率(1.2%)高于女性(1.0%)。迄今为止,627名(72.0%)iFOBT呈阳性的人员接受了结肠镜检查,其中3.7%患有结直肠癌,30.6%患有腺瘤。
试点结直肠癌筛查的成功实施及令人满意的过程指标表明,通过泰国现有的卫生服务扩大有组织的结直肠癌筛查是可行的。